Abstract

A Case of Severe Thyroid Eye Disease Treated with Tocilizumab

Aysel Mehmet*, Eirini Kanella Panagiotopoulou, Aristeidis Konstantinidis, Charalampos Papagoras, Panagiotis Skendros, Doukas Dardabounis, Athanasia Maria Mikropoulou and Georgios Labiris

This is a case report describing a patient with severe thyroid eye disease complicated with dysthyroid optic neuropathy that was unresponsive to intravenous steroids and orbital radiotherapy but responded well to intravenous tocilizumab.

Published Date: 2020-10-27; Received Date: 2020-10-05